The global laparoscopic retrieval bag market size was valued at USD 274.3 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2030. The increasing prevalence of lifestyle-related chronic conditions like urological disorders, gastrointestinal (GI) disorders, and cancer, coupled with a growing focus on patient safety during complex surgical procedures, are anticipated to be key factors driving the overall market growth. For instance, according to WHO, colorectal cancer is globally recognized as the third most common cancer, constituting around 10% of all cancer diagnoses, and stands as the second leading cause of cancer-related fatalities worldwide.
Laparoscopic retrieval bags also referred to as specimen retrieval bags or laparoscopic specimen pouches, are specialized medical tools employed in minimally invasive surgical procedures. These bags are efficient, providing numerous advantages such as reduced risk of infection, minimized tissue trauma, simplified extraction of large specimens, easy removal of fluids, and cost-effectiveness.
The growing adoption of minimally invasive surgeries owing to their advantages, such as reduced surgical trauma, lower infection rates, and shorter hospital stays, are further expected to contribute to the market growth. Advances in technology and surgical expertise have further fueled the adoption of MIS, which, in turn, has boosted the use of retrieval bags. As surgeons become more proficient in laparoscopic techniques and innovative tools like robotic-assisted surgery continue to evolve, the complexity and range of procedures that can be performed minimally invasively continue to expand. Laparoscopic retrieval bags play a crucial role in these procedures, allowing for the safe and efficient removal of specimens and tissues.
Based on the type, the laparoscopic retrieval bag market is segmented into detachable retrieval bags, and non-detachable retrieval bags. The detachable retrieval bags segment is expected to grow at the fastest rate over the forecast period. One of the key benefits offered by these retrieval bags is their capability to securely enclose surgical specimens, tissues, or organs during surgical procedures. By isolating the specimen within the bag, these devices effectively mitigate the risk of spillage or contamination, thus preserving the sterile surgical environment and lowering the likelihood of postoperative infections.
On the basis of technique, the market is segmented into manual and automatic opening. The automatic opening segment held a substantial share in 2023 and is expected to grow at the fastest rate over the forecast period. The automated mechanisms streamline the process of deploying the bag, enabling surgeons to swiftly and effortlessly open it with minimal effort. This saves valuable time during surgical procedures and enhances the precision and control of specimen retrieval.
Furthermore, laparoscopic retrieval bags with automatic openings alleviate the physical strain on surgeons, particularly during lengthy operations. By reducing the manual effort required for bag deployment, they contribute to reduced surgical fatigue and can lead to better overall surgical performance.
Based on application, the laparoscopic retrieval bag market is segmented into gynecology, urology, general surgery, and others. The gynecology segment held a considerable share in 2023 and is expected to grow at the fastest rate over the forecast period. The increase in gynecological diseases and the growing popularity of minimally invasive surgeries in the field of gynecology are significant trends in modern healthcare.
Gynecological diseases, including conditions such as endometriosis, uterine fibroids, and ovarian cysts, are becoming more prevalent due to various factors, including lifestyle changes, hormonal imbalances, and improved diagnostic methods.
The laparoscopic retrieval bag market is segmented into hospitals, clinics, and ambulatory surgical centers based on end-use. The hospital segment dominated the market in 2023. Hospitals are equipped with a wide range of specialized facilities and resources that are often essential for complex surgeries. This includes state-of-the-art operating rooms, advanced surgical equipment, and access to various support services such as diagnostic imaging, laboratories, and blood banks.
These resources are critical for planning, executing, and responding to unforeseen challenges during surgery. In addition, hospitals experience a notably greater volume of patients seeking laparoscopic procedures compared to alternative healthcare environments. This is primarily because hospitals offer a higher level of readiness in managing potential surgical emergencies and provide a broader spectrum of treatment alternatives.
North America held the largest market share in 2023. The primary factor contributing to the market growth includes the increasing preference for laparoscopic surgeries over traditional open surgeries. This shift is driven by several factors, including the presence of key players in the region and competition among them, with a focus on product innovation. Additionally, surgeons are increasingly recommending laparoscopy due to its advantages, such as quicker recovery times and more favorable outcomes. Furthermore, the rising healthcare expenditure in the U.S. is creating favorable conditions for established and emerging market players.
Key players operating in the market are Johnson & Johnson, Medtronic, B. Braun SE, Richard Wolf GmbH, LaproSurge, Vernacare, and Purple Surgical. The market participants are constantly working towards new product development, M&A activities, and other strategic alliances to gain new market avenues. The following are some instances of such initiatives.
In December 2022, Johnson & Johnson agreed to acquire Abiomed for USD 16.6 billion. This acquisition was aimed at expanding Johnson & Johnson's presence in the MedTech industry, particularly as a pioneer in the field of cardiovascular innovation.
In August 2022, Medtronic PLC announced plans to acquire Affera Inc., a medical technology company. This strategic move aimed to expand and enhance Medtronic's cardiovascular portfolio in the medical technology sector.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."